CONNECT
Start a conversation.
We hear from founders working on discovery-stage biology platforms, and from institutional LPs interested in the firm's strategy. Both conversations are welcome. We read every message.
For Founders
We invest at Seed and Series A in computational biology, AI-driven drug discovery, and genomic engineering platforms. Send a brief description of your platform, where you are in scientific validation, and what you are trying to accomplish. A full deck is not required for a first contact. We respond to every company within our thesis.
- Platform science overview (1–2 paragraphs or brief deck)
- Scientific validation status (in silico only / wet-lab confirmation / IND-enabling)
- Team backgrounds and domain expertise
- What you are seeking (capital, scientific perspective, both)
For Limited Partners
Galdera's third fund is in early planning. If you are an institutional LP with an interest in early-stage life sciences venture and a focus on computational approaches to drug discovery, we are selectively taking introductory conversations.
- Prior fund performance materials available under NDA
- Portfolio monitoring reports provided quarterly
- GP-LP calls scheduled biannually
- Advisory Committee positions available for anchor LPs
Our Office
We are located in the Torrey Pines / UCSD biotech corridor, within proximity of the major academic medical centers and research institutes that anchor our investment ecosystem.